References
- Barks-Ruggles E. The globalization of disease: when Congo sneezes, will California get acold? Brookings Rev. 19(4), 30–33 (2001).
- Institute of Medicine. Vaccines for the 21st Century: a Tool for Decision making. National Academy Press, Washington, DC, USA (2000).
- World Health Organization. The World Health Report, 1999: Making a Difference. World Health Organization, Geneva, Switzerland (1999).
- World Health Organization. Assessing the Global Needs for Vaccine Research and Development. World Health Organization, Geneva, Switzerland (2000).
- United Nations Children's Fund. Vaccine Security Ensuring a Sustained, Uninterrupted Supply of Affordable Vaccines. UNICEF, NY, USA (2002).
- Mercer Management Consulting. Lemons Learned: New Procurement Strategies for Vaccines: Final Report to the GA VI Board. Mercer Management Consulting, IL, USA (2002).
- Batson A. Understanding the Vaccine Market and Its Economics: Obstacles and Potential Solutions. Presentation to the Out of the Box Group, 26th July (2001).
- Grabowski H, Vernon J. The Search for New Vaccines: the Effects of the Vaccines for Children Program. AEI Press, DC, USA (1997).
- General Accounting Office. Childhood Vaccines: Ensuring an Adequate Supply Poses Continuing Challenges. US General Accounting Office, DC, USA (2002).
- Institute of Medicine. Financing Vaccines in the 21st Century: Assuring Access and Availability National Academy Press, Washington, DC, USA (2004).
- Hay J, Zammit D. Vaccine Policy Perspectives: Market Strategies. Institute of Medicine, Public Access File (2003).
- Clarke B. Strengthening the supply of routinely recommended vaccines in the US. Presentation to the National Vaccine Advisory Committee, Washington, DC, USA, 11th February (2002).
- DeMasi J, Hansen R, Grabowski H. The price of innovation: new estimates of drug development costs. I Health Econ. 22(2), 325–330 (2003).
- Taylor C, Cutts F, Taylor M. Ethical dilemmas in current planning for polio eradication. Am. J. Public Health 87(6), 922–925 (1997).
- Finkelstein A. Health Policy and Technological Change: Evidence from the Vaccine Industry Working Paper 9460. National Bureau of Economic Research, Cambridge, MA, USA (2003).
- Arnould R, DeBrock L. An Overview of the Market for Vaccines in the United States. Institute of Medicine, Public Access File (2002).
Websites
- Global Alliance for Vaccines and Immunization. Accelerated Development and Introduction of Priority New Vaccines (ADIPs) www.vaccinealliance.org/txt/home/Resources_Documents/Policy_Technical/Accelerating_RD/adip.php Accessed 12 September, 2004.
- Centers for Disease Control and Prevention. United States Vaccine Research: A Delicate Fabric of Public and Private Collaboration (1997). www.cdc.gov/od/nypo/delfab.pdf Accessed September, 2004.